Secondary drug distributors acquired about 70% of drugs in short supply from pharmacies, according to a Congressional report that tracked the pedigrees of 300 drugs (PDF) bought and sold on the gray market.
The report, released today during a Senate Committee on Commerce, Science and Transportation hearing, is part of the investigation into gray market activity that Rep. Elijah Cummings (D-Md.) launched last year.
Read the full story: http://tinyurl.com/c3uqfwb
Source: ModernHealthcare.com
Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges
November 27th 2023Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia.
Read More
Managed Care Cast Presents: Opportunities for Adalimumab Biosimilars, Part 1
November 10th 2023In part 1 of this 2-part podcast, a panel of experts discusses the provider and payer considerations for transitioning patients to biosimilars, approaches to prescribing biosimilars over reference products, and more.
Listen
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Read More
2 Clarke Drive
Cranbury, NJ 08512